Cargando…
Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers
Pneumonia and acute respiratory distress syndrome are common and important causes of respiratory failure in the intensive care unit with a significant impact on morbidity, mortality and health care utilization despite early antimicrobial therapy and lung protective mechanical ventilation. Both clini...
Autores principales: | Chalmers, Sarah, Khawaja, Ali, Wieruszewski, Patrick M, Gajic, Ognjen, Odeyemi, Yewande |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753396/ https://www.ncbi.nlm.nih.gov/pubmed/31559145 http://dx.doi.org/10.5492/wjccm.v8.i5.59 |
Ejemplares similares
-
Biomarker-Concordant Steroid Use in Critically Ill Patients with Pneumonia
por: Odeyemi, Yewande E., et al.
Publicado: (2020) -
Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial
por: Odeyemi, Yewande E., et al.
Publicado: (2022) -
What factors predispose patients to acute respiratory distress syndrome?
por: Odeyemi, Yewande, et al.
Publicado: (2020) -
Rule-Based Cohort Definitions for Acute Respiratory Distress Syndrome: A Computable Phenotyping Strategy Based on the Berlin Definition
por: Li, Heyi, et al.
Publicado: (2021) -
Initial ventilator settings for critically ill patients
por: Kilickaya, Oguz, et al.
Publicado: (2013)